We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AXIA3:BMFBOVESPAAXIA Energia SA Analysis

Data as of 2026-03-13 - not real-time

R$58.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

AXIA3 is trading at R$58, just above the calculated support of R$57.38 and well below the resistance of R$63.14, putting price near a key technical floor. The 20‑day SMA of R$60.24 sits above the 50‑day SMA of R$56.15 and the 200‑day SMA of R$50.68, confirming a bullish trend on the longer horizon. Momentum, however, is mixed: the RSI at 46.3 is neutral while the MACD line sits below its signal, producing a negative histogram of –0.51, a bearish signal in the short term. Volatility remains elevated at 34.8% over the past 30 days, yet the beta of 0.21 indicates the stock moves less than the broader market. Fundamentals show a trailing PE of 25.6 versus an industry average of 23.3, and a forward PE of 10.9, suggesting earnings are expected to accelerate. The dividend yield of 6.27% looks attractive, but the payout ratio of 160% raises concerns about sustainability.
A discounted cash‑flow model values the company at roughly R$23.4, implying the current price is significantly overvalued with only a 1.8% upside potential. Revenue has contracted by 11.3% YoY, while operating margins remain strong at 60.9% and free cash flow exceeds R$7.8 bn, highlighting solid cash generation. The recent Q4 2025 earnings call reaffirmed the dividend policy and underscored the company’s robust cash position of R$25 bn. Sector risk is low for utilities, but regulatory and geographic exposures in Brazil are medium, and the high dividend payout adds an extra layer of risk. Given the mixed technical signals, overvaluation, and dividend sustainability issues, a cautious stance is warranted in the near term. Investors with a longer horizon may still find value in the defensive utility profile, provided they monitor regulatory developments and payout adjustments.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near support
  • bearish MACD histogram
  • high dividend payout ratio

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • forward PE compression
  • strong operating cash flow
  • defensive utility sector

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • sector stability
  • regulatory risk
  • valuation gap vs DCF

Key Metrics & Analysis

Financial Health

Revenue Growth-11.30%
Profit Margin15.89%
P/E Ratio25.6
ROE5.46%
ROA1.35%
Debt/Equity66.72
P/B Ratio1.4
Op. Cash FlowR$14.5B
Free Cash FlowR$7.9B
Industry P/E23.3

Technical Analysis

TrendBullish
RSI46.3
SupportR$57.38
ResistanceR$63.14
MA 20R$60.24
MA 50R$56.15
MA 200R$50.68
MACDBearish
VolumeStable
Fear & Greed Index72.88

Valuation

Fair ValueR$23.39
Target PriceR$59.03
Upside/Downside1.78%
GradeOvervalued
TypeValue
Dividend Yield6.27%

Risk Assessment

Beta0.21
Volatility34.77%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.